Table 4 Clinical differences between patients stratified into two groups by SPBW
Variables | SPBW < 71 (n = 37) | SPBW ≥ 71 (n = 27) | p value |
|---|---|---|---|
Age, years | 53.5 ± 14.4 | 60.3 ± 14.7 | 0.07 |
Male, n (%) | 20 (54.1) | 19 (70.4) | 0.29 |
BMI, kg/m2 | 26.2 ± 4.7 | 24.8 ± 4.7 | 0.26 |
sBP, mmHg | 147.6 ± 36.3 | 144.1 ± 24.1 | 0.67 |
NYHA ≥ III, n (%) | 30 (81.1) | 21 (77.8) | 0.99 |
NT-proBNP, pg/ml | 4402 (1947, 9566) | 4413 (2698, 14875) | 0.36 |
HHD, n (%) | 20 (54.1) | 8 (29.6) | 0.09 |
DCM, n (%) | 8 (21.6) | 10 (37.0) | 0.28 |
RASi, n (%) | 31 (83.8) | 25 (92.6) | 0.50 |
Beta-blockers, n (%) | 32 (86.5) | 27 (100) | 0.13 |
MRA, n (%) | 28 (75.7) | 22 (81.5) | 0.80 |
SGLT2i, n (%) | 19 (51.4) | 11 (40.7) | 0.56 |
LVDd, mm | 59.0 (54.8, 63.4) | 63.4 (60.0, 68.3) | 0.030 |
IVST, mm | 10.3 (8.6, 11.7) | 9.0 (8.0, 11.1) | 0.28 |
PWT, mm | 10.9 (8.8, 12.6) | 9.7 (8.0, 11.5) | 0.17 |
LVMI, g/m2 | 141.8 (129.3, 190.1) | 166.4 (139.9, 185.5) | 0.19 |
LVEF, % | 26.6 (23.1, 32.0) | 25.0 (19.4, 30.5) | 0.032 |
LAD, mm | 43.5 (41.3, 46.0) | 43.4 (39.4, 46.5) | 0.98 |
E wave velocity, m/s | 87.4 (79.0, 103.8) | 73.0 (54.2, 93.1) | 0.020 |
E/e’ ratio | 18.1 ± 7.5 | 19.9 ± 6.4 | 0.60 |
Maximum IVC, mm | 15.1 (12.7, 19.6) | 17.5 (14.5, 22.3) | 0.13 |